Cerebrospinal fluid myelin basic protein as a prognostic marker in patients with head injury.
Despite increasing interest in identifying biochemical and serologic markers to judge the severity of closed head injury in comatose patients, clinical variables remain the most readily available methods for assessing prognosis. In a series of 35 severely head-injured comatose patients, the cerebrospinal fluid (CSF) level of myelin basic protein (MBP) was analyzed by radioimmunoassay. MBP levels during the first week after injury were significantly correlated with the Glasgow outcome score at 7 days (p less than .005), 3 months (p less than .005), and 6 months (p less than .05) postinjury. Measurement of CSF MBP appears to be a useful laboratory adjunct to clinical assessment, for judging the outcome of severely head-injured patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003128:Coma / Q000175:diagnosis; D006259:Craniocerebral Trauma / Q000134:cerebrospinal fluid* / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D009185:Myelin Proteins / Q000134:cerebrospinal fluid*; D011379:Prognosis; D011863:Radioimmunoassay
D009185:Myelin Proteins